tiprankstipranks
Iovance Biotherapeutics (GB:0JDK)
NASDAQ:0JDK
UK Market

Iovance Biotherapeutics (0JDK) Technical Analysis

5 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Iovance Biotherapeutics’s (0JDK) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Iovance Biotherapeutics is a Sell.
Iovance Biotherapeutics’s (0JDK) 20-Day exponential moving average is 3.91, while Iovance Biotherapeutics’s (0JDK) share price is $3.9, making it a Buy.
Iovance Biotherapeutics’s (0JDK) 50-Day exponential moving average is 3.72, while Iovance Biotherapeutics’s (0JDK) share price is $3.9, making it a Buy.

Iovance Biotherapeutics (0JDK) Pivot Points

Jun 05, 2026, 10:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.58
3.73
3.81
3.96
4.05
4.20
4.29
Fibonacci
3.73
3.82
3.87
3.96
4.05
4.11
4.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Iovance Biotherapeutics (0JDK) Moving Averages

Jun 05, 2026, 10:33 PM
Period
Simple
Exponential
MA5
4.08Buy
4.13Buy
MA10
4.08Buy
4.04Buy
MA20
3.82Buy
3.91Buy
MA50
3.68Buy
3.72Buy
MA100
3.43Buy
3.46Buy
MA200
2.88Buy
2.99Buy
Iovance Biotherapeutics’s (0JDK) 10-Day exponential moving average is 4.04, while Iovance Biotherapeutics’s (0JDK) share price is $3.9, making it a Buy.
Iovance Biotherapeutics’s (0JDK) 100-Day exponential moving average is 3.46, while Iovance Biotherapeutics’s (0JDK) share price is $3.9, making it a Buy.
Iovance Biotherapeutics’s (0JDK) stock price is $3.9 and Iovance Biotherapeutics’s (0JDK) 50-day simple moving average is 3.68, creating a Buy signal.
Iovance Biotherapeutics’s (0JDK) stock price is $3.9 and Iovance Biotherapeutics’s (0JDK) 100-day simple moving average is 3.43, creating a Buy signal.
Iovance Biotherapeutics’s (0JDK) stock price is $3.9 and Iovance Biotherapeutics’s (0JDK) 200-day simple moving average is 2.88, creating a Buy signal.

Iovance Biotherapeutics (0JDK) Technical Indicators

Jun 05, 2026, 10:33 PM
Name
Value
Implied Action
RSI (14)
62.36
Neutral
STOCH (9,6)
58.51
Neutral
STOCHRSI (14)
65.26
Neutral
MACD (12,26)
0.15
Sell
ADX (14)
17.06
Buy
Williams %R
-14.17
Sell
CCI (14)
97.21
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
54.47
Neutral
ROC
22.52
Buy
Iovance Biotherapeutics’s (0JDK) Relative Strength Index (RSI) is 62.36, creating a Neutral signal.
Iovance Biotherapeutics’s (0JDK) Trend Strength Indicator (ADX) is 17.06, creating a Buy signal.
Iovance Biotherapeutics’s (0JDK) Commodity Channel Index (CCI) is 97.21, creating a Neutral signal.
Iovance Biotherapeutics’s (0JDK) Price Rate of Change (ROC) is 22.52, creating a Buy signal.

FAQ

Is 0JDK a Buy, Hold, or Sell?
Based on 0JDK’s technical indicators, 0JDK is a Strong Buy.
    What is 0JDK’s RSI (14)?
    0JDK’s RSI (14) is 62.36, which suggests 0JDK is a Neutral.
      What is 0JDK’s MACD?
      0JDK’s MACD is 0.15, which suggests 0JDK is a Sell.
        What is 0JDK’s 5-day moving average?
        0JDK’s 5-day moving average is 4.08, which suggests 0JDK is a Buy.
          What is 0JDK’s 20-day moving average?
          0JDK 20-day moving average is 3.82, which suggests 0JDK is a Buy.
            What is 0JDK’s 50-day moving average?
            0JDK’s 50-day moving average is 3.68, which suggests 0JDK is a Buy.
              What is 0JDK’s 200-day moving average?
              0JDK’s 200-day moving average is 2.88, which suggests 0JDK is a Buy.
                What is 0JDK’s Williams % R (14)?
                0JDK’s Williams % R (14) is -14.17, which suggests 0JDK is a Sell.
                  What is 0JDK’s CCI (14)?
                  0JDK’s CCI (14) is 97.21, which suggests 0JDK is a Neutral.
                    What is the share price of Iovance Biotherapeutics?